In oncology, PET is known to contribute substantially to localization of tumors and
metastases and to control of therapy. One particularly attractive application is the assay of …

Nonivasive assessment of programmed cell death is currently an attractive research topic for
the follow-up of tumor therapy and myocardial infarction. Apoptosis imaging with 99mTc …

1377 Objectives It has been shown recently that [18 F] C-SNAT can be used to detect early
response to therapy in tumors by PET via a mechanism of caspase 3-triggered cyclization …

In vivo monitoring of apoptosis during anticancer therapy has attracted intense research
interest as a potential assay to predict treatment outcome. From all apoptosis-detecting …

[en] Apoptosis or programmed cell death is an important form of cell death. Apoptosis is
involved in numerous human pathological conditions, such as neurodegenerative diseases …

Apoptosis (programmed cell death) and necrosis (uncontrolled cell death) are two distinct
processes of cell death that have been described. Non-invasive molecular imaging of these …

One of the current challenges in oncology is to develop imaging tools to early detect the
response to conventional chemotherapy and adjust treatment strategies when necessary …

After several decades of debate, it is now widely acknowledged that apoptosis, also known
as programmed cell death, is central to homoeostasis and normal development and …

Previously, we reported a small-molecular-weight peptide, single amino acid chelae
(99mTc)-conjugated phosphatidylserine-binding peptide (SAAC (99mTc)-PSBP-6), with high …

The early assessment of a solid tumor's response to conventional or new drug therapy to
complement or replace current RECIST (or other clinical) criteria remains an elusive goal …